ISPOR Patient Council
ISPOR has been committed to engaging patients as a key constituency since 2012 when the Society first invited patient representatives to participate in the Health Technology Assessment (HTA) Roundtable held during their 17th Annual International Meeting. The Society launched its Patient Representatives Roundtables initiative at its 2013 Annual European Congress. Since then, ISPOR has held annual Patient Representatives Roundtables in North America and Europe. The Society hosted its first Patient Roundtable in Latin America in September 2017 and is planning its first for Asia-Pacific in 2018. The Society introduced a patient membership category in 2015 that includes special member benefits, such as discounted membership and conference registration rates and travel grants. ISPOR also has established a Patient Centered Special Interest Group that has an active working group on Patient Engagement in Research.
The mission of the ISPOR Patient Council is to determine how best to engage patient representatives in research and decision making processes and in ISPOR strategy.
The ISPOR Patient Council will be composed of the following:
Qualifications for Patient Council leadership include:
The council will also include at least five advisory members (i.e. key opinion leaders from EPF, NHC, PCORI, or similar organizations as needed)
Qualifications for advisory members include: